Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Olopatadine Evolute
- Development stage
- Unknown
- Lead developer
- Mati Therapeutics
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Olopatadine Evolute is a sustained-release ocular drug delivery system developed by Mati Therapeutics for the treatment of ocular allergies, specifically allergic conjunctivitis. It utilizes the proprietary Evolute Punctal Plug Delivery System (PPDS), which consists of a non-biodegradable silicone punctal plug containing a drug-eluting core. Once inserted into the punctum (tear duct), the device provides controlled, preservative-free release of olopatadine into the tear film over an extended period, typically several weeks. Olopatadine acts as a selective histamine H1 receptor antagonist and mast cell stabilizer, inhibiting the release of inflammatory mediators. This delivery method is designed to improve patient compliance and therapeutic consistency compared to traditional topical eye drops by providing a continuous dose of medication without the need for frequent administration.
- Brand names
- Evolute
- Other names
- Olopatadine PPDSOlopatadine Punctal PlugOlopatadine Evolute®
02
Targets
HRH1 (Histamine H1 Receptor)HRH2 (Histamine H2 Receptor)HRH3 (Histamine Receptor H3)S100A1 (S100 calcium-binding protein A1)S100A12 (S100 calcium-binding protein A12)S100A13 (S100 calcium-binding protein A13)S100A2 (S100 calcium-binding protein A2)S100B (S100 Calcium-Binding Protein B)
Beyond the preview
Go deeper on Olopatadine Evolute.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Olopatadine Evolute.